⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Genomics Market Outlook 2026-2035 - Featuring Profiles of Illumina, Thermo Fisher Scientific, and Qiagen
globenewswire.com
ILMN
TMO
QGEN
NVDA
AMGN
DHR
DGX
AGNC
BIIB
MYGN
PACB
BIO
BioTech Social Announces Advisory Board to Advance Financial Innovation for Life Science Companies
globenewswire.com
ABSI
VEEV
AMGN
JNJ
PFE
BMY
GILD
BIIB
Major Depressive Disorder Clinical Trial Pipeline Boom as 75+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
AXSM
VRTX
RLMD
VSTA
PRAX
NBIX
ALTO
LLY
JNJ
MRK
ABBV
BMY
REGN
BIIB
ANVS
ALEC
LEXX
COYA
NVO
IONQ
NVDA
AMD
INTC
GOOG
MSFT
AMZN
TSLA
AAPL
META
IBM
CRM
ADBE
NFLX
CMCSA
VZ
T
KO
PEP
MCD
DIS
BA
CAT
GE
XOM
CVX
JPM
BAC
WFC
GS
MS
V
MA
HD
WMT
COST
PG
PFE
MRNA
GILD
AMGN
NVS
TAK
EXAS
CRSP
EDIT
NTLA
INCY
ALKS
ACAD
AZN
TEVA
BHC
LULU
UBER
LYFT
SPCE
PLTR
SNOW
DDOG
CRWD
ZS
PANW
FTNT
NOW
ADSK
MCHP
NXPI
ON
QCOM
MU
WDC
SE
MELI
BABA
JD
PDD
NTES
BIDU
IQ
VIPS
NIO
XPEV
LI
RIVN
LCID
PLUG
FCEL
BE
SPWR
ENPH
SEDG
RUN
NEO
CLSK
CRBU
RXRX
DTIL
ADPT
CYTK
IMUX
MNKD
SRPT
BNTX
RVMD
ACRS
EXEL
FGEN
GNTX
HRMY
INSM
ITRM
KODK
LPCN
NCLH
OCGN
ORGO
PACB
PBYI
PEGA
PLRX
PRGS
PTON
PYPL
QGEN
QRVO
RDNT
REPL
ROKU
RYAAY
SAVA
SBAC
SCLX
SDRL
SEIC
SIRI
SMCI
SNPS
SOFI
SPOT
SSYS
STX
SWKS
SYK
TCOM
TEAM
TER
TGT
TMO
TMUS
TXN
UAL
ULTA
UPS
VRSK
WDAY
XEL
XYL
ZBRA
Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape
globenewswire.com
ABBV
JNJ
NVS
UCB
PFE
GSK
AMGN
LLY
Chronic Pain Market Poised for Growth Through 2036 as Rising Prevalence and Innovative Therapies Drive New Opportunities
globenewswire.com
ABBV
LLY
AMGN
TEVA
TONX
PFE
VRTX
AXSM
LEXX
Global Microcarriers Market Poised for Strong Growth Through 2034, Fueled by Rising Cell Therapy, Vaccine Production and Biomanufacturing Demand
globenewswire.com
TMO
AMZN
AMGN
BMY
DHR
REGN
BNTX
MRK
COR
BDX
BIIB
GILD
VRTX
MDLZ
BKR
BIO
GEHC
MDT
ES
Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2 Inhibitors, and Cell Therapies | DelveInsight
prnewswire.com
VBIO
AMGN
JNJ
BMY
IMVT
TileDB Rebrands as Tile.ai, Names New CEO and Secures Strategic Investment
prnewswire.com
AMGN
PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor
prnewswire.com
MRK
AMGN
AZN
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players
globenewswire.com
ABT
AMGN
BDX
DHR
ISRG
QDEL
TMO
TRIB
XRAY
BIO